Tilray

Tilray is a prominent pharmaceutical and healthcare entity founded in 2018, specializing in the research, cultivation, production, and distribution of medical cannabis and cannabinoid-based products. Operating with a workforce of 1,000-5,000 employees, the company maintains a robust international presence across North America, Europe, and Australia. Learn about Tilray's global headquarters for detailed information regarding their operational footprint in Leamington, Ontario.

The company leverages state-of-the-art automated production models to deliver high-quality medical marijuana, CBD wellness solutions, and beverage ingredients. Tilray’s strategic focus encompasses both B2B and B2C markets, positioning them as a pioneer in the evolving global cannabis landscape. Their diverse product portfolio addresses patient needs through innovative pharmaceutical and wellness applications, supported by rigorous research and development initiatives. Meet Tilray's team to explore the leadership driving these advancements in the healthcare sector.

Tilray competes within a complex market environment, facing competition from major industry players such as Canopy Growth, Jazz Pharmaceuticals, and Curaleaf. Despite the competitive landscape, the company continues to expand its international market share through strategic partnerships and a commitment to high-quality standards. By integrating data analytics and advanced supply chain management, Tilray maintains a forward-looking approach to the pharmaceutical industry, ensuring consistent delivery of their medical and lifestyle products to a global consumer base.